Vulvar Pathology Flashcards

1
Q

Most important prognostic factor

A

Regional lymph node involvement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

5 year survival with negative nodes

A

96%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

5 year survival with 2 positive nodes

A

80%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

5 year survival with 3/> nodes

A

12%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Stage 1A

A
  • <2cm
  • stromal invasion 1mm
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Stage 1B

A
  • > 2cm
  • > 1mm invasion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Stage 2

A

Tumor of any size with spread to vagina, Anusara or urethra

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Stage 3A1

A

One lymph node >/= 5mm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Stage 3A2

A

= 2 nodes <5mm in size

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Stage3B1

A

> 2 nodes size >/=5mm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Stage 3B2

A

3 or more nodes, size <5mm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Stage 3C

A

Extracapsular spread plus nodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Stage 4A1

A

Invades upper urethra +/- vaginal/bladder/rectal mucosa or pelvic bone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Stage 4A2

A

Fixed or ulcerated inguinal femoral node

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Stage 4B

A

Any distant mets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is lichen sclerosus

A

A benign, chronic, progressive dermatological condition characterized by marked inflammation, epithelial thinning, itching and pain.

17
Q

What is the most common location of LS

A

Anogenital 85-98%

Can develop on any skin surface and also oral mucosa

18
Q

What age group is affected in women for VLS

A

Prepubertal and postmenopausal

More commonly postmenopausal

19
Q

What are the main factors that contribute to VLS

A
  • genetic
  • hormonal: hypoestrogenic states
  • autoimmune
20
Q

What autoimmune diseases ate associated with LS (5)

A
  • vitiligo
  • alopecia Areata
  • thyroid disease
  • pernicious anaemia
  • diabetes mellitus
21
Q

What is the hallmark symptom of LS

A

Vulvar itching
Worse at nights and disturbs sleep

Other symptoms
- pain
- anal discomfort
- dyspareunia
- dysuria

22
Q

What are the examination features of LS

A

-White atrophied papules that coalesce into plaques
- follicular plugging
- fissuring at posterior fourchette
- fused labia and buried clitoris
- narrowed introitus

23
Q

What is the first line treatment for LS

A

High potency corticosteroids

Clobetasol propionate
- daily x 1/12
- alt daily x 1/12
- twice weekly x 1/12

Review after 2-3mnths

24
Q

What is second line therapy

A

Tacrolimus

Must do biopsy prior to treatment

25
Q

What is the lifetime risk of developing Squamous cell carcinoma with LS

A

<5%

26
Q

What is the predisposing factor for differentiated VIN

A

Lichen sclerosus

27
Q

What is the incidence of vulvar cancer

A

3.7: 100,000

28
Q

What is the common age group of vulvar ca

A

> 65yrs

29
Q

What are predisposing factors for vulvar ca

A
  • lichen sclerosus 4%
  • high risk hpv